• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Campbell Alliance

Anonymous board for Campbell Alliance.
Replies
5
Views
10K
Anonymous
Replies
9
Views
9K
Anonymous